Zantac Cancer Settlement

Have you or a loved one been diagnosed with cancer after using Zantac, Zantac OTC or Generic Ranitidine?

You may be eligible for the Zantac Cancer Settlement:

The popular heartburn drug Zantac has recently been reported to contain elevated levels of a chemical that could cause cancer. The levels of the chemical N-nitrosodimethylamine (NDMA), a known human carcinogen (cancer-causing substance) found in this drug, have been tested to be anywhere from 3,000 to 26,000 times higher than the legal limit set by the Food and Drug Administration.

In late October 2019, Sanofi issued a voluntary recall of all Zantac OTC (over-the-counter) tablets, which includes Zantac 150, Zantac 150 Cool Mint, and Zantac 75, in light of the FDA’s findings. Since late September 2019, several generic ranitidine medications, including OTC and prescription drugs, have also been recalled. Check out the FDA’s website for the latest recall information

Now, users may be able to file a Zantac lawsuit if they are diagnosed with:

Bladder Cancer
Liver Cancer
Breast Cancer
Lung Cancer
Colorectal Cancer
Pancreatic Cancer
Esophageal/Throat/Nasal Cancer
Prostate Cancer
Stomach Cancer

Free Case Review

No upfront fees - No fees unless you recover

Are you submitting this form on the behalf of someone else?

Have you Used Zantac, Zantac OTC or Generic Ranitidine for at least 1 year?

What year did you start taking Zantac?

What year did you stop (Recalled 2020)?

Have you been Diagnosed with:

What year were you diagnosed?

If diagnosed with Kidney or Liver cancer would you like Toxic Water Lawsuit Claim Forms?

Have you ever been represented by an attorney previously for any Zantac matter?

Have you lived, worked or attended school within Four Miles of any of the following addresses prior to your diagnosis?

One of our attorneys will review your case and respond to you within 24 hours

By submitting my request, I confirm that I have read and agree to the Privacy Statement and Terms of Service of this site and that I consent to receive emails, phone calls and/or text message offers and communications from Zeccola & Selinger LLC and at any telephone number or email address provided by me, including my wireless number if provided. I understand there may be a charge by my wireless carrier for such communications.I understand these communications may be generated using an autodialer and may contain pre-recorded messages and that consent is not required to utilize Consumer Help Center. I understand that this authorization overrides any previous registrations on a federal or state Do Not Call registry

What is Zantac?

Zantac, the brand name for ranitidine, is an H2 receptor antagonist (H2 blocker) used to treat conditions like heartburn, acid indigestion, ulcers, and GERD by reducing stomach acid production. The molecular structure of ranitidine includes a nitrite and a DMA group. These components can react together to form NDMA, a substance that the FDA identifies as a probable human carcinogen. Essentially, this means that ranitidine can produce NDMA through its internal chemical reactions, exposing individuals to NDMA with every dose, which may increase their risk of cancer.

Is Zantac still on the market?

The FDA recalled all Zantac products on April 1, 2020. Before this, Zantac was available as both a prescription and an over-the-counter medication, in both branded and generic forms. Here is a brief timeline of Zantac and its generic counterpart, ranitidine:

Brand (Zantac) v. Generic (ranitidine)

In 1983, the FDA approved Zantac as a prescription medication.
By 1995, Zantac was approved for over-the-counter sale.
In 1997, a generic version of the prescription, called ranitidine, was introduced to the market.

NOTICE: The popular heartburn drug Zantac has recently been reported to contain elevated levels of a chemical that could cause cancer.

Settlements have already been reported! Act Now!

Helping Victims Nationwide.